Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study
Shirley M. Bluethmann(Pennsylvania State University), L. Kay Bartholomew(The University of Texas Health Science Center at Houston), Sally W. Vernon(The University of Texas Health Science Center at Houston), Caitlin C. Murphy(The University of Texas Southwestern Medical Center), Michelle Mollica(National Cancer Institute), Jasmin A. Tiro(Chicago Department of Public Health)
Cited by 52
Related Papers
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021
|Gastroenterology|2021|819
Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy
|JNCI Journal of the National Cancer Institute|2019|394
Prevalence of cancer survivors in the United States
|JNCI Journal of the National Cancer Institute|2024|240
Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
|The American Journal of Gastroenterology|2013|227